LCN2 and acute kidney injury: AI-based prediction models can play a dual role in addressing these challenges. On one hand, AI-based prediction models hold the potential to discover biomarkers for subclinical AKI, aligning with biomarkers such as NGAL and cystatin C, improving early detection.